Reirradiation of Spinal Column Metastases
- 27 June 2011
- journal article
- research article
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 187 (7) , 406-415
Abstract
For reirradiation of spinal column metastases, intensity-modulated radiation therapy (IMRT) reduces the dose to the spinal cord, while allowing longer treatment times. We analyzed the potential of volumetric modulated arc therapy (VMAT) to reduce treatment time and number of monitor units (MU). In CT datasets of 9 patients with spinal column metastases, the planned target volume (PTV) encompassed the macroscopic tumor including the spinal cord or medullary cone, respectively. The prescribed dose for the target was 40 Gy, but median spinal cord dose was intended to be < 26 Gy. We compared a posterior (3D-PA) static field technique, a two-field wedge technique (3D-wedge) and 5-/7-beam IMRT with VMAT. Conformity index (CI), homogeneity index (HI40), dose volume histogram (DVH) parameters, treatments delivery time (T), and MU were analyzed. Dosimetry was validated with EDR2-film/ionization chambers. PTV coverage was insufficient for 3D-conformal radiotherapy (3D-CRT) when spinal cord tolerance was respected. The IMRT approach provided excellent results but has the longest treatment time. VMAT produced dose distributions similar to IMRT with shorter treatment times (VMAT: mean 4:49 min; IMRT: mean 6:50 min) and fewer MU (VMAT: 785; IMRT: 860). Reduced conformity and increased homogeneity for VMAT when compared to IMRT were observed. An absolute deviation between measured and calculated dose of +0.70 ± 3.69% was recorded. γ-Index analysis showed an agreement of 91.33 ± 3.53% for the 5%/5 mm criteria. For this paradigm, VMAT produces high quality treatment plans with homogeneity/conformity similar to static IMRT, shorter treatment times, and fewer MU. Verification measurements showed good agreement between calculation and delivered dose, leading to clinical implementation.Keywords
This publication has 23 references indexed in Scilit:
- Der Stellenwert der Strahlentherapie bei symptomatischen Wirbelkörperhämangiomen (sWKH)*Strahlentherapie und Onkologie, 2010
- Radiation Therapy for Early Stages of Morbus LedderhoseStrahlentherapie und Onkologie, 2009
- Strahlentherapie bei schmerzhafter Kniegelenkarthrose (Gonarthrose)Strahlentherapie und Onkologie, 2009
- Prospective Study of Exclusive Strontium-/Yttrium-90 β-Irradiation of Primary and Recurrent Pterygia with No Prior Surgical ExcisionStrahlentherapie und Onkologie, 2009
- Prevention of pterygium recurrence by postoperative single-dose β-irradiation: a prospective randomized clinical double-blind trialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Postoperative irradiation of pterygium with 90Sr eye applicatorInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1999
- Prospective trial of intraoperative mitomycin C in the treatment of primary pterygium.British Journal of Ophthalmology, 1995
- Postoperative irradiation for pterygium: Guidelines for optimal treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Management of pterygium with surgery and radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1994
- Pterygium treated with excision and postoperative beta irradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992